- Entering largely untapped Chinese CBD skin care market
- Health benefits widely recognized
- Vibrant online marketing campaigns underway
Chinese women, it will be no surprise to learn, are as beauty conscious as their sisters in other countries. For centuries, they have employed a variety of cosmetic embellishments to enhance social status and, perhaps, catch someone’s eye. Lip coloring has been in vogue for at least 1,000 years, and, at some point, the application of powdered rice to lighten skin tone became fashionable. But beauty is more than skin deep, which is perhaps why ChineseInvestors.com, Inc. (OTCQB: CIIX) is launching a line of hemp-infused skin care products in China. The cannabinoid content of the line makes these products more than just cosmetics. The health virtues of cannabinoids are now widely accepted.
It’s not always that you’re known by the company you keep. Cannabidiol (CBD), the main active ingredient in CIIX’s new product line up, is, like THC, derived from cannabis sativa, but unlike its notorious associate, it is not psychotropic. Increasingly, it is being recognized to have therapeutic potential. Indeed, at a United States Senate Caucus, pre-clinical research (including both cell culture and animal models) into CBD was said to have shown ‘a range of effects that may be therapeutically useful, including anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties’ (http://cnw.fm/nKbl8). There are already products, like Sativex, that contain CBD, however, there are few directed to skincare, either in the West or in China. As such, this offers CIIX a lucrative opportunity to be a first mover in this space (http://cnw.fm/vU6Pu).
It’s an opportunity the company has embraced vigorously. CIIX recently announced that that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., had completed the record filing process with the China Food & Drug Administration (CFDA) for its first line of non-industrial hemp-infused skin care products (http://cnw.fm/Oqs6F). CIIX expects to launch the ‘CBD Magic Hemp Series’ skin care line before the end of the year. The initial ‘CBD Magic Hemp Series’ launch will include:
- The CBD BIOTECH Brightening and Refreshing Moisturizer – intended to balance the skin’s moisture while forming a protective, moisturizing layer
- The CBD BIOTECH Perfecting Shield Primer – intended to even skin tone while covering fine lines and minimizing the look of pores; and
- The CBD BIOTECH Peptide Collagen Solution – intended to moisturize and firm the skin while smoothing fine lines and reducing signs of aging.
CIIX targets mainly Chinese-speaking consumers and operates an online store in the free trade zone of Shanghai, China. The company also recently established, through its wholly owned subsidiary ChineseHempOil.com, Inc., a club-style Hemp Education Center in San Gabriel, California, where it is based, to educate interested parties regarding the potential health benefits of non-industrial hemp and hemp-derived CBD. CIIX also engaged Arizona-based Launch Haus LLC, a specialist in digital direct-to-consumer marketing and product branding, to assist in growing the company’s worldwide sales of hemp-based CBD products.
Moreover in June 2017, CIIX incorporated CBD Biotechnology Inc. in British Columbia, Canada, as part of its efforts to enter the medical marijuana market there. CIIX also plans to launch a Chinese language Yelp-style mobile app for locating dispensaries and discussing cannabis products in the US.
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.cannabisnewswire.com